Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Flavanols, a subclass of flavonoids found in foods such as cocoa, tea, apples, and berries, have been studied for their potential effects on components of metabolic syndrome, which includes abdominal obesity, dyslipidemia, hypertension, and insulin resistance. Scientific validation for their use primarily comes from epidemiological studies, randomized controlled trials, and meta-analyses examining the effects of flavanol-rich foods and extracts. Several studies have demonstrated that flavanol consumption can improve endothelial function, reduce blood pressure, and enhance insulin sensitivity—core features of metabolic syndrome. For example, cocoa flavanols have been shown to improve flow-mediated dilation and reduce systolic and diastolic blood pressure in both healthy subjects and those with risk factors for cardiovascular disease. Other studies have suggested modest improvements in lipid profiles and glycemic control with regular flavanol intake. However, while findings are promising, the overall quality of evidence is moderate, with some trials showing only small or inconsistent benefits, and results can be influenced by the source, dose, and bioavailability of flavanols. Additionally, most studies have used concentrated extracts or specific foods rather than isolated flavanols, making it difficult to attribute effects solely to this compound. In summary, while there is scientific evidence supporting the use of flavanols for metabolic syndrome, the evidence is moderate and further high-quality, long-term studies are needed to confirm efficacy and clarify optimal intake.

More about Flavanols
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Flavanols

Products containing Flavanols